Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
An epigenetically distinct breast cancer cell subpopulation promotes collective invasion
Jill M. Westcott, … , Yang Xie, Gray W. Pearson
Jill M. Westcott, … , Yang Xie, Gray W. Pearson
Published April 6, 2015
Citation Information: J Clin Invest. 2015;125(5):1927-1943. https://doi.org/10.1172/JCI77767.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 17

An epigenetically distinct breast cancer cell subpopulation promotes collective invasion

  • Text
  • PDF
Abstract

Tumor cells can engage in a process called collective invasion, in which cohesive groups of cells invade through interstitial tissue. Here, we identified an epigenetically distinct subpopulation of breast tumor cells that have an enhanced capacity to collectively invade. Analysis of spheroid invasion in an organotypic culture system revealed that these “trailblazer” cells are capable of initiating collective invasion and promote non-trailblazer cell invasion, indicating a commensal relationship among subpopulations within heterogenous tumors. Canonical mesenchymal markers were not sufficient to distinguish trailblazer cells from non-trailblazer cells, suggesting that defining the molecular underpinnings of the trailblazer phenotype could reveal collective invasion-specific mechanisms. Functional analysis determined that DOCK10, ITGA11, DAB2, PDFGRA, VASN, PPAP2B, and LPAR1 are highly expressed in trailblazer cells and required to initiate collective invasion, with DOCK10 essential for metastasis. In patients with triple-negative breast cancer, expression of these 7 genes correlated with poor outcome. Together, our results indicate that spontaneous conversion of the epigenetic state in a subpopulation of cells can promote a transition from in situ to invasive growth through induction of a cooperative form of collective invasion and suggest that therapeutic inhibition of trailblazer cell invasion may help prevent metastasis.

Authors

Jill M. Westcott, Amanda M. Prechtl, Erin A. Maine, Tuyen T. Dang, Matthew A. Esparza, Han Sun, Yunyun Zhou, Yang Xie, Gray W. Pearson

×

Figure 3

The expression of canonical mesenchymal traits is not sufficient to induce the trailblazer phenotype.

Options: View larger image (or click on image) Download as PowerPoint
The expression of canonical mesenchymal traits is not sufficient to indu...
(A) Representative FACS analysis of EpCAM and CD49f expression in the indicated cells (n = 3). (B) Representative FACS analysis of EpCAM and CD49f expression in parental SUM149 and SUM229 cells (n = 3). (C) HCC1143, SUM149, and SUM229 cells were sorted into daughter subpopulations based on the level of EpCAM expression. Sorted EpCAMhi and EpCAMlo cells grown in organotypic culture and stained with phalloidin and the percentage of invasive spheroids for the EpCAMhi and EpCAMlo subpopulations derived from the HCC1143, SUM149, and SUM229 cells (mean + SD, n = 3) are shown. Scale bar: 50 μm. (D) Heat map showing the mRNA expression of EMT-related genes, including epithelial markers (CDH1, CLDN3, CLDN7, and EPCAM) and mesenchymal markers (FOXC1, FOXC2, SNAI1, SNAI2, TWIST1, VIM, ZEB1, and ZEB2). Expression is the mean of 2 biological replicates. (E) Heat map showing the mRNA expression of basal cytokeratins (KRT14 and KRT5), the basal transcription factor p63, and epithelial cytokeratins (KRT8 and KRT18). Expression is the mean of 2 biological replicates. T, trailblazer; O, opportunist; P, parental.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 3 X users
Referenced in 1 patents
On 1 Facebook pages
On 2 videos
162 readers on Mendeley
See more details